Academy Sports' second-quarter fiscal 2024 results reflect soft demand trends due to macroeconomic uncertainties.
Vous n'êtes pas connecté
Eli Lilly (LLY) beats second-quarter estimates for earnings and sales. It raises its guidance for 2024 on strong demand for Mounjaro and Zepbound.
Academy Sports' second-quarter fiscal 2024 results reflect soft demand trends due to macroeconomic uncertainties.
PD's second-quarter fiscal 2025 results benefit from an expanding customer base. However, weak top-line guidance negatively impacts share price.
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
AVGO's third-quarter fiscal 2024 results benefit from strong demand for AI networking and VMware solutions. However, shares fall on weak Q4 guidance.
(Reuters) -Oracle beat estimates for quarterly results and forecast second-quarter revenue growth above estimates on Monday, boosted by growing demand...
Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
RH's second-quarter fiscal 2024 results reflect strong demand despite a challenging housing market.
While the top- and bottom-line numbers for Dick's (DKS) give a sense of how the business performed in the quarter ended July 2024, it could be worth...